Clinical Trials Directory

Trials / Completed

CompletedNCT00632554

The Efficacy of Three Months-prednisolone Therapy for Chronic Eosinophilic Pneumonia

Phase 4, Randomized Study of Three Months-prednisolone Therapy in the Treatment of Chronic Eosinophilic Pneumonia

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
50 (estimated)
Sponsor
Hamamatsu University · Academic / Other
Sex
All
Age
16 Years – 80 Years
Healthy volunteers
Not accepted

Summary

A comparison of 3 months-prednisolone administration with 6 months-prednisolone therapy in the treatment of chronic eosinophilic pneumonia. Three months-prednisolone administration may be as effective as 6 months-therapy.

Conditions

Interventions

TypeNameDescription
DRUGprednisolone 0.5 mg/kg/day for three monthsperiod of treatment
DRUGprednisolone 0.5 mg/kg/day for six monthsperiod of therapy

Timeline

Start date
2008-06-01
Primary completion
2010-03-01
Completion
2010-03-01
First posted
2008-03-10
Last updated
2014-09-19

Locations

1 site across 1 country: Japan

Source: ClinicalTrials.gov record NCT00632554. Inclusion in this directory is not an endorsement.